Los Angeles, CANCT07804186Now EnrollingIRB Ready

Uveal Melanoma Clinical Trial in Los Angeles, CA

Access cutting-edge uveal melanoma treatment through this phase 3 clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.

Sponsored by IDEAYA Biosciences

Quick Self-Assessment

See if you qualify for this Los Angeles location

Preparing your pre-screening questions…

Expert Care in Los Angeles

Access uveal melanoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related uveal melanoma treatment provided free

Apply for This Los Angeles Location

Check if you qualify for this uveal melanoma clinical trial in Los Angeles, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Los Angeles

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Los Angeles site if eligible
  4. 4Begin participation

About This Uveal Melanoma Study in Los Angeles

This is a randomized, multi-center, open-label study of adjuvant darovasertib in participants with non-metastatic uveal melanoma (OptimUM-11)

Sponsor: IDEAYA Biosciences

Who Can Participate

Inclusion Criteria

Primary Uveal Melanoma, classified as high-risk of relapse (AJCC Stage II or Stage 3)
Completed primary local therapy (enucleation, proton beam therapy, plaque brachytherapy)
ECOG performance status of 0 or 1
Adequate organ function
Age 18 or older
Written informed consent and ability to comply
Primary local therapy completed within 120 days before C1D1/randomization.
Contraception requirements

Exclusion Criteria

Previous systemic treatment for Uveal Melanoma
Clinical or radiological evidence of metastatic UM
Concurrent malignant disease with the following exceptions: malignancies that were treated curatively and have not recurred within 2 years prior to randomization, completely resected basal cell and squamous cell skin cancers, any malignancy considered to be indolent and never required systemic therapy, and any type of carcinoma in situ receiving curative therapy (resection)
Known AIDS related illness
History of interstitial lung disease, active pneumonitis, or history of noninfectious pneumonitis requiring steroids
History of syncope may be exclusionary, but will be reviewed on a case-by-case basis
Active Hepatitis B or C infection
Any gastrointestinal condition (eg, inflammatory bowel disease, major gastric or intestinal surgery) that could affect absorption or ability to swallow
Females who are pregnant or breastfeeding
Impaired cardiac function
History of stroke within the last 6 months of randomization
Ongoing use of medication use for infections, other antineoplastic therapies, or other prohibited medications, including medications that interact with the metabolism of darovasertib+crizotinib
allergy to mammalian meat products or gelatin

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Los Angeles?

Yes, this clinical trial (NCT07804186) has an active research site in Los Angeles, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Uveal Melanoma Treatment Options in Los Angeles, CA

If you're searching for uveal melanoma treatment options in Los Angeles, CA, this clinical trial (NCT07804186) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Los Angeles research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced uveal melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all uveal melanoma clinical trials near you to find additional studies recruiting in your area.

More Melanoma Trials in Los Angeles, CA

See all melanoma clinical trials recruiting in Los Angeles — not just this study.

Browse Melanoma Trials in Los Angeles →

Browse More Trials by Condition

Melanoma TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Los Angeles?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Los Angeles, CA